Avita Medical (AVH)

Sydney
Currency in AUD
1.590
+0.015(+0.95%)
Closed·
AVH Scorecard
Full Analysis
3 analysts have revised their earnings upwards for the upcoming period
AVH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.5651.600
52 wk Range
1.5604.520
Key Statistics
Edit
Bid/Ask
1.575 / 1.59
Prev. Close
1.575
Open
1.575
Day's Range
1.565-1.6
52 wk Range
1.56-4.52
Volume
266.04K
Average Volume (3m)
307.16K
1-Year Change
-36.65%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AVH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.112
Upside
+158.62%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Avita Medical News & Analysis

Show more

Avita Medical Company Profile

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company markets, sells, and distributes PermeaDerm, a biosynthetic wound matrix; and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.

Compare AVH to Peers and Sector

Metrics to compare
AVH
Peers
Sector
Relationship
P/E Ratio
−2.4x−9.3x−0.5x
PEG Ratio
0.100.020.00
Price/Book
−30.0x1.7x2.6x
Price / LTM Sales
1.9x4.0x3.0x
Upside (Analyst Target)
136.5%157.6%52.4%
Fair Value Upside
Unlock37.3%8.7%Unlock

Analyst Ratings

2 Buy
1 Hold
1 Sell
Ratings:
4 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 4.112
(+158.62% Upside)

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-0.1651 / -0.0966
Revenue / Forecast
28.83M / 32.59M
EPS Revisions
Last 90 days

AVH Income Statement

FAQ

What Is the Avita Medical Ltd (AVH) Stock Price Today?

The Avita Medical Ltd stock price today is 1.59

What Stock Exchange Does Avita Medical Ltd Trade On?

Avita Medical Ltd is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Avita Medical Ltd?

The stock symbol for Avita Medical Ltd is "AVH."

What Is the Avita Medical Ltd Market Cap?

As of today, Avita Medical Ltd market cap is 212.40M.

What Is Avita Medical Ltd's Earnings Per Share (TTM)?

The Avita Medical Ltd EPS (TTM) is -2.19.

When Is the Next Avita Medical Ltd Earnings Date?

Avita Medical Ltd will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is AVH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Avita Medical Ltd Stock Split?

Avita Medical Ltd has split 5 times.

How Many Employees Does Avita Medical Ltd Have?

Avita Medical Ltd has 260 employees.

What is the current trading status of Avita Medical Ltd (AVH)?

As of 21 June 2025, Avita Medical Ltd (AVH) is trading at a price of 1.59, with a previous close of 1.58. The stock has fluctuated within a day range of 1.57 to 1.60, while its 52-week range spans from 1.56 to 4.52.

What Is Avita Medical Ltd (AVH) Price Target According to Analysts?

The average 12-month price target for Avita Medical Ltd is AUD4.112, with a high estimate of AUD7.98 and a low estimate of AUD1.92. 2 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +158.62% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.